Skip to main content

Pfizer Inc(PFE-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Volume
Day Low33.71
Day High34.11
Open:33.84
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

Free Reports for Pfizer Inc

News for Pfizer Inc

Select a category then submit the form to load news
Motley Fool
Cathie Wood Is Buying This Growth Stock Hand Over Fist Lately. Should You Follow Her Lead?
Motley Fool
Is Pfizer Stock a Buy Now?
Motley Fool
3 Top Stocks to Buy in October and Hold Forever
Motley Fool
3 Stocks to Buy in October That Could Soar More Than 40% Over the Next 12 Months, According to Wall Street
Motley Fool
Could Viatris Stock Help You Become a Millionaire?
Motley Fool
Moderna's Shares Could Take Off if These 2 Things Happen
Motley Fool
Why Pfizer and BioNTech Stocks Zoomed Higher Today
Motley Fool
Where Will Pfizer Be in 5 Years?
Motley Fool
Why CureVac Stock Plunged Today
MarketBeat
5 Stocks That Have Massive Upside According to Analysts
Newswire.ca
Pfizer and BioNTech Receive Health Canada Authorization for XBB.1.5-Adapted Monovalent COVID-19 Vaccine
Barchart
Is Pfizer Stock a Buy Near 52-Week Lows for Its 5.08% Yield?
Barchart
3 Recession-Proof Stocks to Buy Now
Stock Picking, Options Trading for Income
8 October 2023 Covered Calls Trades Yield 24.3% Annualized Returns On Risk
Barchart
2 Undervalued Dividend Stocks with 5% Yields To Buy Near 52-Week Lows
Stock Picking, Options Trading for Income
10 October 2023 Puts Options Trades
Reuters
U.S. CDC panel backs Pfizer’s maternal RSV vaccine to protect infants
Motley Fool
3 Bargain Stocks to Buy in a Market That's Priced for Perfection
Motley Fool
2 Dividend Growth Stocks to Buy Right Now
Motley Fool
With New COVID-19 Boosters in Tow, Which Is the Better Buy: Pfizer, BioNtech, or Moderna Stock?
MarketBeat
Flee to Healthcare Stocks if Recession Rears its Head?
Motley Fool
Pfizer Stock: Bear vs. Bull
Newswire.ca
Purpose Life Sciences Creates Strategic Advisory Board, Appoints Jeffrey B. Kindler and Calum MacRae, MD, PhD, to Further Efforts in Revolutionizing Global Clinical Trial Research
Motley Fool
You Can Pick Up These High-Risk, High-Reward Stocks for Less Than $10
Motley Fool
2 Stocks That Sank Hard on Monday
Newswire.ca
TIME MAGAZINE NAMED GRUPO BIMBO AS THE BEST MEXICAN COMPANY IN THE WORLD
Barchart
Should You Follow Warren Buffett's Lead and Sell HPQ Stock?
MarketBeat
Can These 3 Healthcare Dividend Stocks Deliver Income Growth?
Newswire.ca
ESSA Pharma Announces Initiation of Phase 2 Study Evaluating Masofaniten (EPI-7386) in Combination with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer
Motley Fool
This 1 Number May Completely Change Your Opinion About Moderna
Motley Fool
Want to Collect $500 in Dividends Every Month? Invest $90,000 in These 3 Stocks
Motley Fool
This Market Could Be Worth $10 Billion by 2030 -- 2 Stocks to Buy Now
More Pfizer Inc news

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2023.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2023 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.